(Q34986363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

review article

1 reference

title

Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

Rüdiger Braun-Dullaeus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Victor J Dzau

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Daniel G Sedding

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

English

0 references

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1249-1256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm1102-1249

14 December 2019

exact match

0 references

cites work

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cell biology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

The good smooth muscle cells in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

The intima. Soil for atherosclerosis and restenosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Proliferation and the monoclonal origins of atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cell proliferation in human coronary arteries

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Neointimal formation by circulating bone marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Smooth muscle progenitor cells in human blood

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cell cycle progression: new therapeutic target for vascular proliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Production of transforming growth factor beta 1 during repair of arterial injury

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cell cycle checkpoints: preventing an identity crisis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

How the cyclin became a cyclin: regulated proteolysis in the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

The gene for transcription factor GATA-6 resides on mouse chromosome 18 and is expressed in myocardium and vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

GATA-6 induces p21(Cip1) expression and G1 cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

The expanding role of cell cycle regulators.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1)

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cell cycle-dependent expression of cyclooxygenase-2 in human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Rapamycin inhibits vascular smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenti

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Chimeric DNA-RNA hammerhead ribozyme to proliferating cell nuclear antigen reduces stent-induced stenosis in a porcine coronary model

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Wild-type p53 gene transfer: a novel therapeutic strategy for neointimal hyperplasia after arterial injury

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Therapeutic potential of nitric oxide synthase gene manipulation

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Gene therapy for human bypass grafts

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1249

7 January 2021

Identifiers

DOI

10.1038/NM1102-1249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12411952%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference